Sales orders totaling c. 23.8 MSEK/2.1 MEUR received by Eevia Health Plc
Eevia Health Plc, (”Eevia” or ”The Company”), received several new sales orders totaling c. 23.8 MSEK / 2.1 MEUR from an International nutraceutical brand owner for an extract ingredient with immune health properties.Eevia, a leading health ingredient manufacturer from Finland, received a series of orders for the manufacturing and sale of a berry extract with immune health properties. The customer is a key international customer and an internationally recognized brand leader in the marketplace with a global footprint. The group sold for over USD 1.2 billion globally in 2022. It offers over